Table 3.
The results of univariate analysis of categorical data
Factors | Odds ratio | 95%CI | P |
---|---|---|---|
Gender (male) | 1.35 | 0.85–2.15 | 0.45 |
Age at initial surgery (>32 years) | 4.04 | 0.75–21.89 | 0.13 |
Disease duration (<6 years) | 1.79 | 0.39–8.27 | 0.45 |
Type of disease (chronic continuous) | 2.35 | 0.48–11.35 | 0.36 |
Type of disease (relapse–remitting) | 0.42 | 0.09–1.89 | 0.42 |
Type of disease (acute fulminating) | 1.40 | 0.14–13.8 | 0.58 |
Extent of colitis (left-sided colitis) | 2.24 | 0.37–13.36 | 0.33 |
Severity of colitis (severe) | 1.30 | 0.23–7.36 | 0.67 |
Total dosage of steroid before surgery (>8 g) | 1.08 | 0.24–4.76 | 1.00 |
Dosage of steroid per month just before surgery (>600 mg) | 4.12 | 0.88–19.82 | 0.10 |
Use of immunomodulator (Y) | 1.45 | 0.33–6.44 | 0.71 |
Emergency or urgent operation at first operation (Y) | 0.56 | 0.06–5.00 | 1.00 |
Operation stages (two stage) | 3.22 | 0.37–28.24 | 0.42 |
Operation stages (three stage) | 0.41 | 0.05–3.57 | 0.67 |
Postoperative pelvic abscess (Y) | 1.22 | 0.13–11.27 | 1.00 |